DermTech Inc

+0.03 (+2.03%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)52.58M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$3.9 Million
Adjusted EPS-$0.76
See more estimates
10-Day MA$1.63
50-Day MA$2.32
200-Day MA$3.14
See more pivots

DermTech Inc Stock, NASDAQ:DMTK

12340 El Camino Real, Suite 100, San Diego, California 92130
United States of America
Phone: +1.858.450.4222
Number of Employees: 279


DermTech, Inc. engages in the development and sale of products for the diagnosis and treatment of skin diseases. It markets and develops products that facilitate diagnosis and management of various skin conditions, including skin cancer, inflammatory diseases, and aging-related conditions. Its products and services include melanoma test, smart sticker, and telemedicine option for melanoma test. The company was founded in 1995 and is headquartered in San Diego, CA.